CARE Ratings reaffirms Mukka Proteins at CARE BBB-, outlook Negative
Mukka Proteins (MUKKA) said CARE Ratings has reaffirmed its credit rating at CARE BBB- with a negative outlook. The company is valued at about ₹808 crore.
What happened
Mukka Proteins (MUKKA) told the exchanges on 7 October 2026 at 04:45 PM that CARE Ratings has reaffirmed its credit rating at CARE BBB- with a negative outlook.
From the filing: "Outlook revised from Negative CARE Ratings Limited Long Term Bank Facilities 15.00 CARE BBB-;"
Company snapshot
Mukka Proteins is a micro-cap company, with a market value of about ₹808 crore.
The stock last traded at ₹26.94, against a 52-week range of ₹18.27–₹33.29 (19.1% below the high).
Before this filing the shares had moved −13.9% over the month and +18.8% over three months. Average daily turnover over the last 20 sessions was about ₹2.07 crore.
Promoters held 73.33% at the end of Q1 FY27. Foreign institutions owned 1.73% and domestic institutions 0.00%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 171 | 1.5 | 0.05 |
| Q2 FY26 | 245 | 5.9 | 0.2 |
| Q3 FY26 | 653 | 23.7 | 0.79 |
| Q4 FY26 | 381 | 20.6 | 0.69 |
| Q1 FY27 | 490 | 18.9 | 0.63 |
What history shows
This is not the company's first credit rating disclosure: BCEIE has 1 earlier filing of this kind on record since May 2026.
Market-wide, 1,223 credit rating filings with an impact score of 50 or more saw an average next-day move of +0.1%, with 47% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Whether other agencies take a similar view on the company's credit.
In the news
Recent coverage elsewhere (links open the original publisher):
- Is Mukka Proteins the Best Stock in Its Sector? A Look at the Numbers
- MUKKA PROTEINS LTD. Share Price Today Up 4%
- Mukka Proteins reschedules investor meeting with Suraag Capital to Sep 29
- Mukka Proteins NSE:MUKKA Reg 74(5) Compliance Q2 FY27
- Mukka Proteins Ltd receives USDA NOP - Inputs Attestation from ECOCERT S.A.S., France
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.